395 related articles for article (PubMed ID: 12060188)
1. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
[TBL] [Abstract][Full Text] [Related]
2. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
[TBL] [Abstract][Full Text] [Related]
3. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.
Joyce PR; Mulder RT; Luty SE; McKenzie JM; Rae AM
Acta Psychiatr Scand; 2003 Jul; 108(1):20-3. PubMed ID: 12807373
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.
Akhondzadeh S; Faraji H; Sadeghi M; Afkham K; Fakhrzadeh H; Kamalipour A
J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962
[TBL] [Abstract][Full Text] [Related]
5. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
[TBL] [Abstract][Full Text] [Related]
6. Melancholia: definitions, risk factors, personality, neuroendocrine markers and differential antidepressant response.
Joyce PR; Mulder RT; Luty SE; McKenzie JM; Sullivan PF; Abbott RM; Stevens IF
Aust N Z J Psychiatry; 2002 Jun; 36(3):376-83. PubMed ID: 12060187
[TBL] [Abstract][Full Text] [Related]
7. Relationships among measures of treatment outcome in depressed patients.
Mulder RT; Joyce PR; Frampton C
J Affect Disord; 2003 Sep; 76(1-3):127-35. PubMed ID: 12943942
[TBL] [Abstract][Full Text] [Related]
8. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline.
Joyce PR; Mulder RT; Luty SE; McKenzie JM; Miller AL; Rogers GR; Kennedy MA
Int J Neuropsychopharmacol; 2003 Dec; 6(4):339-46. PubMed ID: 14604448
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.
Fabre LF; Scharf MB; Itil TM
J Clin Psychiatry; 1991 Jun; 52 Suppl():62-7. PubMed ID: 2050651
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia.
Roose SP; Glassman AH; Attia E; Woodring S
Am J Psychiatry; 1994 Dec; 151(12):1735-9. PubMed ID: 7977878
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
[TBL] [Abstract][Full Text] [Related]
12. Thyroid indices and response to fluoxetine and nortriptyline in major depression.
Gendall KA; Joyce PR; Mulder RT; Luty SE
J Psychopharmacol; 2003 Dec; 17(4):431-7. PubMed ID: 14870956
[TBL] [Abstract][Full Text] [Related]
13. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
Uher R; Dernovsek MZ; Mors O; Hauser J; Souery D; Zobel A; Maier W; Henigsberg N; Kalember P; Rietschel M; Placentino A; Mendlewicz J; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2011 Jul; 132(1-2):112-20. PubMed ID: 21411156
[TBL] [Abstract][Full Text] [Related]
14. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
[TBL] [Abstract][Full Text] [Related]
16. An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
Uher R; Tansey KE; Dew T; Maier W; Mors O; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; McGuffin P
Am J Psychiatry; 2014 Dec; 171(12):1278-86. PubMed ID: 25017001
[TBL] [Abstract][Full Text] [Related]
17. Age may affect response to antidepressants with serotonergic and noradrenergic actions.
Mulder RT; Watkins WG; Joyce PR; Luty SE
J Affect Disord; 2003 Sep; 76(1-3):143-9. PubMed ID: 12943944
[TBL] [Abstract][Full Text] [Related]
18. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
[TBL] [Abstract][Full Text] [Related]
19. Nortriptyline for treatment-resistant depression.
Nierenberg AA; Papakostas GI; Petersen T; Kelly KE; Iacoviello BM; Worthington JJ; Tedlow J; Alpert JE; Fava M
J Clin Psychiatry; 2003 Jan; 64(1):35-9. PubMed ID: 12590621
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Kok RM; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
